Collen M. Masimirembwa

Corner Rekai Tangwena & Josiah Tongogara Avenue
Harare, HA, Zimbabwe

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 89 publications

Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populations.

Current knowledge in pharmacogenomics and precision medicine: perspectives of the PGRN global PGx committee on improving drug therapies in underrepresented ethnic populations.

Journal: Pharmacogenomics

Published: August 11, 2026

Correction: Li et al. Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers. J. Pers. Med. 2021, 11, 457.

Correction: Li et al. Evaluation of 1β-Hydroxylation of Deoxycholic Acid as a Non-Invasive Urinary Biomarker of CYP3A Activity in the Assessment of Inhibition-Based Drug-Drug Interaction in Healthy Volunteers. J. Pers. Med. 2021, 11, 457.

Journal: Journal of personalized medicine

Published: May 22, 2026

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Model-based clinical utility of pharmacogenetic testing and its potential population impact on the use of essential medicines in Zimbabwe.

Journal: Frontiers in pharmacology

Published: April 25, 2026

Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe.

Opportunities and challenges for the implementation of pharmacogenomics in supportive care for gastrointestinal cancer patients in Zimbabwe.

Journal: Pharmacogenomics

Published: December 09, 2025

Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use.

Actionable Pharmacogenomics and Essential Medicines: An Analysis of WHO and African Lists for Safer and Efficacious Drug Use.

Journal: Clinical pharmacology and therapeutics

Published: November 26, 2025

The Burden of Adverse Drug Reactions in Africa in the Context of Pharmacogenetics-Based Clinical Guidelines.

The Burden of Adverse Drug Reactions in Africa in the Context of Pharmacogenetics-Based Clinical Guidelines.

Journal: Clinical pharmacology and therapeutics

Published: November 26, 2025

Pharmacogenomic Impact on Breast Cancer Survival for Black Zimbabwean Patients on Tamoxifen.

Pharmacogenomic Impact on Breast Cancer Survival for Black Zimbabwean Patients on Tamoxifen.

Journal: JCO global oncology

Published: November 19, 2025

CYP2D6 Pharmacogenetics in Nigerian Sickle Cell Disease: Phase 1 of Implementing Pharmacogenomics Testing for Effective Care and Treatment in Africa (iPROTECTA) program.

CYP2D6 Pharmacogenetics in Nigerian Sickle Cell Disease: Phase 1 of Implementing Pharmacogenomics Testing for Effective Care and Treatment in Africa (iPROTECTA) program.

Journal: Gates open research

Published: November 05, 2025

A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case Report.

A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case Report.

Journal: Cancer management and research

Published: October 08, 2025

Haematological, renal and hepatic toxicity profiles of infusional 5-fluorouracil versus capecitabine in African gastrointestinal cancer patients: a retrospective cohort study.

Haematological, renal and hepatic toxicity profiles of infusional 5-fluorouracil versus capecitabine in African gastrointestinal cancer patients: a retrospective cohort study.

Journal: Ecancermedicalscience

Published: September 26, 2025

Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe.

Doxorubicin-induced early-onset chronic progressive cardiotoxicity, pharmacogenetics and survival among breast cancer patients in Zimbabwe.

Journal: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Published: May 19, 2025

Incidence and associated risk factors of anti-tuberculosis drug induced liver injury among TB patients.

Incidence and associated risk factors of anti-tuberculosis drug induced liver injury among TB patients.

Journal: BMC infectious diseases

Published: May 05, 2025

Showing 1-12 of 89

Last Updated: 09/26/2026